ARCHIVES

Two OAM Advisors Criticize Third over ACS Membership

This article is from The Cancer Letter archive.

Vol. 19 No. 30 | July 23, 1993

Download PDF Visit The Full Archive

Related Articles

Edward Benz Named President Of Dana-Farber Cancer Institute.

July 28, 2000

Phase 1 Study Asked to Determine If Drug Administration Timing Improves Results

April 4, 1986

HER2+ Tumors Increase Risk Of Recurrence, Study Finds

November 27, 2009

Clinical Study Section’s Workload Up 50 Percent, Evidence That More Investigators Submitting R01s

January 17, 1992

Hoogstraten Resignation Sidetracks Kansas’ Move to Comprehensive Status, Threatens Core Grant

February 15, 1980

Top NCI Officials Pledge No Further Consolidation of Clinical Trials System

December 5, 2014